Avita Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $117k | 8.5k | 13.72 |
| 2023-09-30 | $103k | 7.0k | 14.61 |
| 2023-06-30 | $213k | 13k | 17.01 |
| 2022-12-31 | $16k | 2.4k | 6.60 |
| 2022-09-30 | $19k | 3.2k | 6.02 |
| 2022-06-30 | $11k | 2.2k | 5.00 |
| 2022-03-31 | $65k | 7.8k | 8.39 |
| 2021-12-31 | $188k | 16k | 11.97 |
| 2021-09-30 | $24k | 1.4k | 17.38 |
| 2021-06-30 | $28k | 1.4k | 20.28 |
| 2021-03-31 | $27k | 1.4k | 19.55 |
| 2020-12-31 | $215k | 12k | 18.55 |
| 2020-09-30 | $14k | 632 | 22.73 |
| 2020-06-30 | $84k | 2.8k | 30.41 |